Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue - Other
Ratios

Perspective Therapeutics (CATX) Receivables - Other (2016 - 2025)

Perspective Therapeutics' Receivables - Other history spans 14 years, with the latest figure at $487000.0 for Q4 2024.

  • For Q4 2024, Receivables - Other rose 4770.0% year-over-year to $487000.0; the TTM value through Dec 2024 reached $487000.0, up 4770.0%, while the annual FY2024 figure was $487000.0, 4770.0% up from the prior year.
  • Receivables - Other for Q4 2024 was $487000.0 at Perspective Therapeutics, up from $10000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $487000.0 in Q4 2024 and bottomed at $2000.0 in Q4 2022.
  • The 5-year median for Receivables - Other is $24000.0 (2020), against an average of $96500.0.
  • The largest annual shift saw Receivables - Other tumbled 63.95% in 2020 before it surged 4770.0% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $31000.0 in 2020, then grew by 3.23% to $32000.0 in 2021, then tumbled by 93.75% to $2000.0 in 2022, then surged by 400.0% to $10000.0 in 2023, then soared by 4770.0% to $487000.0 in 2024.
  • Per Business Quant, the three most recent readings for CATX's Receivables - Other are $487000.0 (Q4 2024), $10000.0 (Q4 2023), and $2000.0 (Q4 2022).